Centre’s COVID-19 vaccination drive will lead to profiteering by pvt companies: Forum

·2-min read

New Delhi, Apr 21 (PTI) A national association of doctors and scientists on Wednesday accused the Centre of 'lending the COVID-19 vaccination drive to profiteering' by private companies rather than ensuring public financing of the programme.

In a statement, the Progressive Medicos and Scientists Forum, said the Centre’s move is “bound to lend the vaccine prices to market manipulation for maximising private profits'.

'Rather than ensuring entirely public financing of vaccination, which makes far better epidemiological and economic sense, the government has lent even the vaccination drive to profiteering by private companies by announcing that 50 per cent of all the doses shall now be routed through open market.

“This is bound to lend the vaccine prices to all manner market manipulation for maximising private profits. Promises of free vaccination it appears are good only for winning elections, and dumping the people thereafter,' it said.

The forum said the central government commands the financial resources to extend grants to, and thereby demand answerability of private manufacturers.

“In a situation where there is already a critical shortage of vaccine doses, this implies that the states shall have to bargain at their level with the manufacturers for the best price, and shall in probability have to out-bid each other to be able to secure enough doses to meet their respective demands.

“The situation demanded of the Centre to procure vaccine supplies at a much reasonable cost through public sector and extend liberal grants to the states,' it added.

The Centre had on Monday announced that everyone above 18 years of age would be eligible to get vaccinated against COVID-19 from May 1. It also allowed states, private hospitals and industrial establishments to procure the vaccine doses directly from manufacturers.

Under the third phase of the national vaccination drive commencing next month, the vaccine manufacturers would supply 50 per cent of their monthly Central Drugs Laboratory (CDL) released doses to the central government and would be free to supply the remaining 50 per cent doses to state governments and in the open market.

PTI GJS SRY